Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.192 EUR | -1.81% | -4.49% | -7.45% |
Mar. 14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
Mar. 11 | Abionyx: reduced net loss in 2023 | CF |
Sales 2024 * | 4.6M 4.95M | Sales 2025 * | 7.1M 7.64M | Capitalization | 38.39M 41.33M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.46M | Net income 2025 * | -9M -9.69M | EV / Sales 2024 * | 7.61 x |
Net cash position 2024 * | 3.4M 3.66M | Net Debt 2025 * | 100K 108K | EV / Sales 2025 * | 5.42 x |
P/E ratio 2024 * |
-7.45
x | P/E ratio 2025 * |
-6.27
x | Employees | 61 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.01% |
1 day | -1.81% | ||
1 week | -4.49% | ||
Current month | -4.64% | ||
1 month | +14.62% | ||
3 months | +13.96% | ||
6 months | -11.83% | ||
Current year | -7.45% |
Managers | Title | Age | Since |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Director of Finance/CFO | - | 08-04-30 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 15-02-05 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 1.192 | -1.81% | 14,251 |
24-06-07 | 1.214 | -1.94% | 47,681 |
24-06-06 | 1.238 | +0.16% | 15,702 |
24-06-05 | 1.236 | -0.96% | 29,457 |
24-06-04 | 1.248 | 0.00% | 17,131 |
Real-time Euronext Paris, June 10, 2024 at 11:15 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.45% | 42.26M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- ABNX Stock